Prudential Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Sell
37,349
-11,079
-23% -$3.18M 0.01% 618
2025
Q1
$14.9M Sell
48,428
-18,113
-27% -$5.58M 0.02% 449
2024
Q4
$23.5M Buy
66,541
+12,104
+22% +$4.27M 0.03% 347
2024
Q3
$19.5M Sell
54,437
-5,042
-8% -$1.81M 0.03% 456
2024
Q2
$18.9M Sell
59,479
-156,875
-73% -$50M 0.03% 445
2024
Q1
$49.7M Buy
216,354
+123,167
+132% +$28.3M 0.07% 237
2023
Q4
$20.5M Buy
93,187
+36,902
+66% +$8.11M 0.03% 438
2023
Q3
$12.7M Sell
56,285
-28,603
-34% -$6.46M 0.02% 568
2023
Q2
$18.7M Sell
84,888
-63,645
-43% -$14M 0.03% 464
2023
Q1
$33.3M Buy
148,533
+31,288
+27% +$7.01M 0.05% 315
2022
Q4
$32.6M Sell
117,245
-59,556
-34% -$16.6M 0.05% 323
2022
Q3
$37M Buy
176,801
+78,671
+80% +$16.5M 0.06% 283
2022
Q2
$23.1M Buy
98,130
+6,074
+7% +$1.43M 0.04% 416
2022
Q1
$16.5M Buy
92,056
+21,057
+30% +$3.78M 0.02% 563
2021
Q4
$15.3M Sell
70,999
-63,600
-47% -$13.7M 0.02% 591
2021
Q3
$24.8M Buy
134,599
+38,772
+40% +$7.16M 0.03% 425
2021
Q2
$17.2M Sell
95,827
-33,682
-26% -$6.04M 0.02% 571
2021
Q1
$21.7M Sell
129,509
-62,032
-32% -$10.4M 0.03% 465
2020
Q4
$29.1M Sell
191,541
-9,661
-5% -$1.47M 0.05% 338
2020
Q3
$20.3M Sell
201,202
-28,413
-12% -$2.87M 0.04% 418
2020
Q2
$27.8M Sell
229,615
-91,065
-28% -$11M 0.05% 311
2020
Q1
$30.4M Sell
320,680
-169,740
-35% -$16.1M 0.07% 278
2019
Q4
$43.2M Buy
490,420
+150,440
+44% +$13.3M 0.06% 326
2019
Q3
$27.1M Buy
339,980
+221,000
+186% +$17.6M 0.04% 461
2019
Q2
$9.29M Sell
118,980
-223,633
-65% -$17.5M 0.01% 869
2019
Q1
$40.2M Sell
342,613
-25,250
-7% -$2.96M 0.07% 305
2018
Q4
$40.1M Sell
367,863
-97,367
-21% -$10.6M 0.07% 289
2018
Q3
$59.5M Buy
465,230
+103,474
+29% +$13.2M 0.09% 224
2018
Q2
$40.9M Buy
361,756
+58,404
+19% +$6.61M 0.06% 355
2018
Q1
$34.1M Buy
303,352
+68,460
+29% +$7.69M 0.05% 411
2017
Q4
$34.8M Sell
234,892
-2,024
-0.9% -$299K 0.05% 452
2017
Q3
$27.8M Sell
236,916
-292,648
-55% -$34.3M 0.04% 514
2017
Q2
$68.7M Buy
529,564
+165,528
+45% +$21.5M 0.1% 212
2017
Q1
$49.3M Buy
364,036
+15,345
+4% +$2.08M 0.08% 281
2016
Q4
$50M Buy
348,691
+152,111
+77% +$21.8M 0.08% 272
2016
Q3
$23.2M Sell
196,580
-108,604
-36% -$12.8M 0.04% 514
2016
Q2
$32.3M Sell
305,184
-38,938
-11% -$4.12M 0.05% 375
2016
Q1
$38.3M Buy
344,122
+6,118
+2% +$682K 0.07% 290
2015
Q4
$52.9M Buy
338,004
+78,333
+30% +$12.3M 0.1% 216
2015
Q3
$34.1M Buy
259,671
+39,757
+18% +$5.22M 0.07% 310
2015
Q2
$38.3M Sell
219,914
-24,760
-10% -$4.31M 0.07% 313
2015
Q1
$42.2M Sell
244,674
-17,950
-7% -$3.1M 0.07% 301
2014
Q4
$34M Sell
262,624
-10,180
-4% -$1.32M 0.06% 334
2014
Q3
$35.1M Sell
272,804
-21,312
-7% -$2.74M 0.07% 312
2014
Q2
$26M Buy
294,116
+6,992
+2% +$619K 0.05% 405
2014
Q1
$27M Buy
287,124
+5,400
+2% +$508K 0.05% 376
2013
Q4
$31.9M Sell
281,724
-74,140
-21% -$8.38M 0.06% 317
2013
Q3
$28.1M Sell
355,864
-44,700
-11% -$3.52M 0.06% 327
2013
Q2
$26.4M Buy
+400,564
New +$26.4M 0.06% 330